Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

EHS nephropathy. A long-term morphological and immunohistochemical study.

K Matsui1

  • 1Department of Immunology, Niigata University School of Medicine, Japan.

Virchows Archiv. B, Cell Pathology Including Molecular Pathology
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Prostate cancer after subcapsular prostatectomy diagnosed as benign prostate hypertrophy--clinico-pathological analysis].

Nihon Hinyokika Gakkai zasshi. The japanese journal of urology·1992
Same author

CPT-11 in combination with cisplatin for advanced non-small-cell lung cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1992
Same author

[New antitumor antimetabolites--gemcitabine and DMDC].

Gan to kagaku ryoho. Cancer & chemotherapy·1992
Same author

Heavy ion-induced chromosome breakage studied by premature chromosome condensation (PCC) in Syrian hamster embryo cells.

International journal of radiation biology·1992
Same author

Lung carcinoma with spindle cell components: sixteen cases examined by immunohistochemistry.

Human pathology·1992
Same author

Partial seizures in two cases of metachromatic leukodystrophy: electrophysiologic and neuroradiologic findings.

Journal of child neurology·1992

Rats immunized with a tumor developed progressive kidney damage and significant protein in their urine. This new EHS nephropathy model mimics human membranous nephritis stages.

Area of Science:

  • Nephrology
  • Immunology
  • Pathology

Background:

  • Membranous nephritis is a leading cause of nephrotic syndrome in adults.
  • Current animal models do not fully recapitulate the human disease progression.
  • A novel model is needed to study the pathogenesis and potential treatments for membranous nephritis.

Purpose of the Study:

  • To develop and characterize a new rat model of membranous nephritis using Engelbreth-Holm-Swarm (EHS) tumor immunization.
  • To investigate the temporal development of kidney pathology and immune complex deposition in this model.
  • To compare the immunological findings with existing models like Heymann nephritis.

Main Methods:

  • Rats were immunized with EHS tumor and Freund's complete adjuvant (FCA).

Related Experiment Videos

  • Urinary protein excretion was monitored over one year.
  • Kidney tissues were analyzed using immunofluorescence, light microscopy, and electron microscopy at various time points.
  • Immunohistochemical analysis was performed to compare with Heymann nephritis.

    • Main Results:

    • Immunized rats exhibited progressive proteinuria starting from week 14, exceeding 1 g/day after one year.
    • Immunofluorescence revealed granular immunoglobulin deposits in glomeruli from week 10 onwards.
    • Light and electron microscopy showed glomerular basement membrane thickening, podocyte effacement, and intramembranous electron-dense deposits, consistent with stages I-III of human membranous nephritis.
    • Antigenic cross-reactivity was observed between EHS nephropathy and Heymann nephritis.

    Conclusions:

    • Rats immunized with EHS tumor develop a novel form of membranous nephritis, termed EHS nephropathy.
    • This model exhibits key pathological features and temporal progression mirroring human membranous nephritis.
    • EHS nephropathy provides a valuable tool for studying the immunopathogenesis of membranous nephritis and for evaluating therapeutic interventions.